Rivernorth Capital Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Rivernorth Capital Management’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54K	Hold	147,970	–	–	﹤0.01%	573
2026 Q1	$1.72K	Hold	147,970	–	–	﹤0.01%	527
2025 Q4	$1.6K	Hold	147,970	–	–	﹤0.01%	466
2025 Q3	$3.88K	Sell	147,970 -1,930	-1%	-$51	﹤0.01%	454
2025 Q2	$3.52K	Sell	149,900 -100	-0.1%	-$2	﹤0.01%	327
2025 Q1	$1.62K	Hold	150,000	–	–	﹤0.01%	338
2024 Q4	$3.3K	Hold	150,000	–	–	﹤0.01%	366
2024 Q3	$2.25K	Hold	150,000	–	–	﹤0.01%	342
2024 Q2	$4.5K	Hold	150,000	–	–	﹤0.01%	364
2024 Q1	$3.83K	Hold	150,000	–	–	﹤0.01%	390
2023 Q4	$4.65K	Hold	150,000	–	–	﹤0.01%	367
2023 Q3	$3.39K	Hold	150,000	–	–	﹤0.01%	466
2023 Q2	$10.8K	Hold	150,000	–	–	﹤0.01%	410
2023 Q1	$22.1K	Hold	150,000	–	–	﹤0.01%	424
2022 Q4	$15K	Hold	150,000	–	–	﹤0.01%	523
2022 Q3	$5K	Hold	150,000	–	–	﹤0.01%	744
2022 Q2	$5K	Hold	150,000	–	–	﹤0.01%	721
2022 Q1	$12K	Hold	150,000	–	–	﹤0.01%	732
2021 Q4	$48K	Hold	150,000	–	–	﹤0.01%	564
2021 Q3	$39K	Hold	150,000	–	–	﹤0.01%	473
2021 Q2	$81K	Hold	150,000	–	–	﹤0.01%	416
2021 Q1	$65K	Buy	+150,000	New	+$141K	﹤0.01%	393

Other funds holding COEPW

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Rivernorth Capital Management's COEPW Position: Q2 2026 in Review

Rivernorth Capital Management held its Coeptis Therapeutics Warrants (COEPW) position steady in Q2 2026 at 147,970 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Rivernorth Capital Management first reported a position in COEPW in Q1 2021 and has held it in 22 quarters since. The position peaked at $81K in Q2 2021. 3 funds tracked by Wall St. Rank hold COEPW as of Q2 2026.

Rivernorth Capital Management held 147,970 shares of Coeptis Therapeutics Warrants worth $1.54K as of Q2 2026.
Rivernorth Capital Management left its Coeptis Therapeutics Warrants share count unchanged in Q2 2026.
Coeptis Therapeutics Warrants made up ﹤0.01% of Rivernorth Capital Management's portfolio in Q2 2026, its #573 holding.
Rivernorth Capital Management first reported a position in Coeptis Therapeutics Warrants in Q1 2021 and has held it in 22 quarters since.
Rivernorth Capital Management's Coeptis Therapeutics Warrants position peaked at $81K in Q2 2021.
3 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2026.

Based on Rivernorth Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.